NASDAQ$ANAB

Anaptysbio Inc · Q4 2017 earnings

Q4 2017 earnings · · Investor relations

Headline financials

Total Revenue

$3M

Previous: $16.7M-82.0%
EPS (adj)

-$0.30

Previous: -$1.62+81.5%
Capital Expenditures

$124K

Previous: $1K+12300.0%
Free Cash Flow

-$4.93M

Previous: -$5.57M+11.4%
Net Income

-$6.86M

Previous: -$4.58M-49.9%
Operating Income

-$7.15M

Previous: -$3.17M-125.3%
Gross Profit

-$4.61M

Previous: -$2.26M-103.6%
Cash & Equivalents

$81.2M

Previous: $51.2M+58.5%
Total Assets

$329M

Previous: $62.2M+429.7%
Stock-Based Comp

$4.38M

Previous: $1.16M+277.4%

Revenue & EPS history

Anaptysbio · Revenue · Quarterly

$3M

Q4 2017-82%vs Q4 2016
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2017

Historical avgQ4 2017

-1.7%

Avg return

Earnings day

-1.5%

Avg return

5 days after

-2.2%

Avg return

30 days after

51%

20 / 39 earnings

Positive

+15.8%

Q4 2019

Best reaction

-71.3%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.7%-7.0%-20.1%
Q4 2025+14.5%+13.0%+9.2%
Q3 2025+3.5%-2.2%+27.7%
Q1 2025+0.9%+2.6%+18.2%
Q4 2024+4.8%+2.1%+15.5%
Q3 2024+11.4%+6.9%+18.7%
Q2 2024-2.1%+0.9%+13.3%
Q1 2024-9.1%-1.9%-9.0%
Q4 2023+5.1%-5.4%-10.6%
Q3 2023+6.0%-0.1%-9.3%
Q2 2023+1.3%+1.6%+6.5%
Q1 2023-9.5%-13.3%-12.9%
Q4 2022-1.4%-5.1%-12.6%
Q3 2022+0.7%+6.5%-3.0%
Q2 2022-6.2%+6.2%+7.0%
Q1 2022-11.6%-10.1%-14.3%
Q4 2021-3.5%-5.4%-14.6%
Q3 2021+8.9%+2.9%-11.2%
Q2 2021-1.0%+0.4%+15.0%
Q1 2021+3.0%+10.5%+0.6%
Q4 2020+8.4%+4.2%-19.9%
Q3 2020-1.5%-0.3%-18.7%
Q2 2020-5.6%-8.4%-14.4%
Q1 2020+0.2%+13.0%+10.3%
Q4 2019+15.8%+21.9%-11.0%
Q3 2019-71.3%-69.6%-61.2%
Q2 2019-1.4%-5.2%-20.5%
Q1 2019-6.8%-0.7%-3.5%
Q4 2018-1.6%-4.4%+1.8%
Q3 2018-16.1%-19.0%-16.5%
Q2 2018+4.6%+6.8%+10.2%
Q1 2018+0.5%+0.6%-18.8%
Q4 2017-6.6%-9.1%-26.6%
Q3 2017+1.3%+2.7%+37.1%
Q2 2016+0.8%-5.2%+46.0%
Q2 2017+0.8%-5.2%+46.0%
Q1 2016-1.1%+0.2%-15.9%
Q4 2016-1.1%+7.4%-12.4%
Q1 2017+2.5%+7.4%-12.4%
Q3 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro